05 · Access & Industry
Your work health plan may stop paying for weight-loss drugs
1 min readEmployers added GLP-1 coverage fast. Now some are dropping it because of the cost.
In 2026, about two in three employer health plans covered GLP-1 weight-loss drugs, up from about one in five the year before. Now some are pulling back. PepsiCo, Starbucks and Lowe's are among the big names reported to be cutting coverage.
The reason is cost. The drugs run $600 or more a month. And workers often change jobs before the long-term health savings arrive, so the employer paying today rarely gets the benefit. One insurer found that covering the drugs raised average health costs by $7,000 per employee in the first year.
For people losing coverage, the choice is hard: pay $300 or more a month themselves, or stop taking it. A cheaper generic is not expected in the US until at least 2031.
DisclaimerEducational news and research awareness content. Not medical advice.Read full disclaimer ▾
This page shares third-party news coverage, official research listings, and public clinical updates for educational awareness only. Catalyst does not present this information as medical advice, treatment guidance, or a claim of safety, efficacy, or approval.
Related context
How this story connects across the peptide landscape.
GLP-1 use for weight loss nearly quadrupled in two years
A 2026 national survey found that 11% of adults reported currently using a GLP-1 medicine for weight loss
GLP-1 medicines joined America's long weight-loss history instead of replacing it
Continue reading · Access & IndustryPeptide News / Access & IndustryFor the first time, world health officials set rules for treating child obesity — and drugs come last20minutos · Oct 6, 2026 · scroll to read